Pharmacy-led programme improves surgery outcomes for patients with diabetes

Glycaemic control programme improves post-surgery outcomes for diabetic patients.

US researchers found that a pharmacy-led glycaemic control programme improved postsurgical outcomes for such patients. In the image, surgeons operate on a patient

Patients with diabetes and stress-induced hyperglycaemia are at increased risk of complications following surgery.

Researchers from the Kaiser Permanente Center for Health Research in Portland, Oregon, found that a pharmacy-led glycaemic control programme improved post-surgical outcomes for such patients.

The programme involved a team of dedicated ‘glycaemic pharmacists’, who were available seven days a week to manage intravenous insulin, calculate insulin doses, and manage parenteral nutrition, among other responsibilities.

Compared with a cohort of patients who underwent surgery before the programme was introduced, patients treated in the programme were more likely to have good glycaemic control after surgery (odds ratio [OR] 2.24 in year 1; 95% confidence interval [CI] 1.85–2.72; P<0.0001) and were less likely to develop hypoglycaemia (OR 0.38 in year 1; 95% CI 0.31–0.46; P<0.0001).

Patients treated in the programme were also less likely to require readmission in the three months following surgery and incurred lower medical costs during six-month follow up.

In American Journal of Pharmacy Benefits
(2015;7:e126–e134), the researchers say such programmes could help reduce variability around the implementation of glycaemic control guidelines. 


[1] Mosen DM, Mularski KS, Mularski RA et al. Pharmacist glycemic control team associated with improved perioperative glycemic and utilization outcomes. American Journal of Pharmacy Benefits 2015;7:e126–e134.

Last updated
Clinical Pharmacist, CP, January 2016, Vol 8, No 1;8(1):DOI:10.1211/PJ.2015.20200111

You may also be interested in